Emerging Insights on Adverse Events During ART and Implications for Treatment

Recent data presented at CROI 2021 provide insights on the clinical significance of INSTIs and weight gain. Here are my takeaways regarding cardiovascular and metabolic implications of INSTI-associated weight gain.

Darcy Wooten, MD Released: May 5, 2021

Healthcare professionals need better understanding of the processes involved with weight gain in patients taking antiretroviral therapy. New and upcoming data are providing valuable insights.

Gregory Huhn, MD, MPHTM Released: June 17, 2021

Watch this dynamic faculty discussion on the impact of emerging ART safety and tolerability data on ART initiation and switch strategies.

Joseph J. Eron, Jr., MD Darcy Wooten, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Registered Nurses: 1.0 Nursing contact hour Pharmacists: 1.0 contact hour (0.1 CEUs) Released: May 11, 2021 Expired: May 10, 2022

Introduction

INSTIs and Metabolic Toxicity

NRTIs and Metabolic Toxicity

Switching ART for Tolerability

Switching ART for Comorbidities

Gain expert insight on the impact of emerging ART safety and tolerability data on ART initiation and switch strategies.

Joseph J. Eron, Jr., MD Darcy Wooten, MD Released: May 11, 2021

Hear insights and answers to audience questions from Joseph J. Eron, Jr., MD, and Darcy Wooten, MD, on HIV ART safety and tolerability including recent data on weight gain and metabolic implications with INSTIs and NRTIs.

Joseph J. Eron, Jr., MD Darcy Wooten, MD Released: July 6, 2021